Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

104 results about "Injury model" patented technology

Injury-causing device for experimental investigation of deceleration injury and method for producing deceleration injury model

InactiveCN101474099AReduced cost of research experimentsEasy to copyDiagnosticsSurgeryAviationExperimental research
The invention discloses an injury making device for deceleration injury experimental research and a method for making a deceleration injury mould. A space for the pulley falling is existed between an upper supporting seat and a substrate. The space is internally and vertically provided with a guided way. The pulley is arranged between the upper supporting seat and the substrate and is matched with the guided way by a rolling device in a rolling way. The substrate is provided with a chopping block and a device used for buffering and deceleration. An animal is fixed on the pulley. A bracket is used for holding the position of the animal needing to be injured. The pulley is caused to freely fall along the guided way so that the position of the animal needing to be injured collides with the chopping chock. The device used for buffering and deceleration controls deceleration so as to form the deceleration damage of the position of the animal needing to be injury, thus obtaining the mould of the deceleration injury. The invention overcomes the shortcomings of the existing injury making device for deceleration injury and the method for making the deceleration injury mould, is economical and scientific and can be widely used in the fundamental research of medicines such as traffic medicine, physical exercise medicine, aviation and aerospace and etc.
Owner:INST OF FIELD OPERATION SURGERY NO 3 MILITARY MEDICL UNIV PLA

Estimation and self-healing control method for blade injury of multi-rotor unmanned aerial vehicle autopilot

The invention relates to an estimation and self-healing control method for a blade injury of a multi-rotor unmanned aerial vehicle autopilot. The estimation and self-healing control method comprises the steps of: firstly, calculating a moment acted on a machine body by an instruction output by an autopilot control system under a non-fault condition and a mathematical model between a force and moment which are acted on the machine body; then constructing a machine body attitude control system state equation, and estimating a moment disturbance variable generated for the machine body after the blade injury by adopting a time domain disturbance observer; then inverting and resolving a parameter estimated value of a blade injury model according to an inverse model of the blade injury mathematical model; and finally, according to the parameter estimated value of the blade injury model, designing a control distribution reconstruction matrix to implement control distribution reconstruction ofthe autopilot. Compared with the prior art, the estimation and self-healing control method for the blade injury of the multi-rotor unmanned aerial vehicle autopilot, which is disclosed by the invention, has the following advantages that a blade injury degree can be estimated online; and by reconstructing a control object mathematical model online, control self-healing of the multi-rotor unmannedaerial vehicle autopilot under the blade injury is implemented, so as to ensure safe and stable flight of an unmanned aerial vehicle under the blade injury condition.
Owner:BEIHANG UNIV

Method for preparing intestinal mucosa injury animal model and applications of model

InactiveCN107137388AInduced convenience and stabilityGastric administration is convenient and simpleCompounds screening/testingOrganic active ingredientsHigh concentrationLaboratory mouse
The invention relates to the fields of medical treatment evaluation and detection technology, and in particular relates to a method for preparing an intestinal mucosa injury animal model and applications of the prepared intestinal mucosa injury animal model. According to the scheme, the medicine L-MSO having good water solubility and realizing convenient and simple gavaging operation is adopted, the mouse intestinal mucosa injury is conveniently and stably induced, and meanwhile, the corresponding tissue pathological change and inflammatory factor change are caused. For the preparation method provided by the invention, the intestinal mucosa injury animal model is prepared from the metabolism injury direction obviously different from the molding direction of immune injury inducing in the prior art, particularly, the low-concentration L-MSO is adopted for preparing the common injured model, wherein the intestinal mucosa of the laboratory mouse has the mild-moderate injury, the high-concentration L-MSO is adopted for preparing the seriously injured model, wherein the intestinal mucosa of the laboratory mouse has the severe injury; the prepared intestinal mucosa injury model has the significant values for the research and practice of inflammatory bowel diseases.
Owner:AFFILIATED HUSN HOSPITAL OF FUDAN UNIV

Application of morindae officinalis oligosaccharide pentasaccharide to preparation of drug for treating myocardial ischemia and reperfusion injury

The invention discloses an application of a morindae officinalis extract and morindae officinalis oligosaccharide pentasaccharide to preparation of a drug for treating myocardial ischemia and / or reperfusion injury and promoting therapeutic angiogenesis. The myocardial ischemia and reperfusion injury belong to secondary injury brought to an organism when the hemoperfusion of myocardium is stopped or poor, i.e., after the myocardium is subjected to ischemia, hypoxia injury, circulation reinstitution and blood supply recovery. The morindae officinalis extract and the morindae officinalis oligosaccharide pentasaccharide both play a role in protecting an in-vivo rat myocardial ischemia reperfusion injury model and an in-vitro purification cultured neonatal rat myocardial cell hypoxia / reoxygenation injury model, and can be used for remarkably reducing the myocardial infarction area and the incidence rate of reperfusion arrhythmias, effectively protecting the form of a myocardial cell and relieving the injury of hypoxia / reoxygenation to the myocardial cell. The therapeutic angiogenesis promotion means that the aims of recovering the blood supply of ischemic myocardium and improving the heart function are achieved through increasing the functional coronary artery branch or side branch under the irritation actions of some methods, including the therapeutic actions of some drugs.
Owner:冯国清 +1

Decellularized epineurium catheter and preparation thereof as well as application to repairing of peripheral nerve injury

The invention belongs to the technical field of biological materials and nerve injury repairing, and particularly relates to a decellularized epineurium catheter and a preparation method thereof as well as application to repairing of a peripheral nerve injury. The biological characteristic of the decellularized epineurium catheter for a pig is researched from such aspects as the porosity, the swelling rate, the in vitro degradation rate and the cytotoxicity test, and the immunogenicity of the catheter is also researched. According to the decellularized epineurium catheter and the preparation method thereof, a rat sciatic nerve transversal injury model is built; after being subjected to microsurgical suturing, a nerve stump line is covered with the decellularized epineurium catheter so as to research the effects of promoting regeneration of nerves, preventing nerve adhesion and formation of nerve tumors. The invention provides the decellularized epineurium catheter which can effectively reduce surrounding nerve adhesion and reduce the occurrence rate of the nerve tumors, and a novel repairing material is provided for repairing of war traumatic surrounding nerve injuries and treatment of causalgia caused by the nerve injuries.
Owner:SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY

Application of Morindae officinalis oligosaccharide 6 glycan in preparation of myocardial ischemia and reperfusion injury resistance medicines

The invention discloses an application of a Morindae officinalis extract product and Morindae officinalis oligosaccharide 6 glycan in the preparation of medicines for resisting myocardial ischemia and / or reperfusion injury and promoting therapeutic angiogenesis. The myocardial ischemia and reperfusion injury are body injuries caused by the afresh circulation establishment and the blood supply recovery during the stopping or abnormality of the myocardial blood perfusion, like ischemic and anoxic injuries. The Morindae officinalis oligosaccharide 6 glycan has a protect effect on an in-vivo rat myocardial ischemia reperfusion injury model and an in-vitro purify-cultured mouse myocardial cell reoxygenation injury model, can substantially reduces the myocardial infarction area, can mitigate the reperfusion arrhythmia, can effectively protect the form of myocardial cells, and can mitigate the injuries of anoxic reoxygenation to the myocardial cells. The therapeutic angiogenesis promotion is characterized in that the ischemic myocardial blood supply recovery and the cardiac function improvement are realized by increasing the functional coronary arterial tree or coronary collateral through some irradiations comprising the treatment effects of some medicines.
Owner:ZHENGZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products